We show that pharmacological stimulation of INSR signaling with Pi has a disease-modifying effect over the course of retinal degeneration, in line with the beneficial effects of INSR stimulation with insulin reported in other neurodegenerative diseases of the brain and retina [6, 40, 41]. The gene discussed is INS; the disease is retinal degeneration.